Variant report
Variant | esv3454967 |
---|---|
Chromosome Location | chr21:16586481-16591979 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:16584216..16586791-chr21:16587079..16588631,2 | MCF-7 | breast: | |
2 | chr21:16584216..16586791-chr21:16587079..16588631,2 | MCF-7 | breast: | |
3 | chr21:16584909..16587844-chr21:16591132..16593725,3 | K562 | blood: | |
4 | chr21:16586940..16589372-chr21:16591214..16594501,3 | MCF-7 | breast: | |
5 | chr21:16584909..16587844-chr21:16591132..16593725,3 | K562 | blood: | |
6 | chr21:16584349..16587030-chr21:16664217..16666665,2 | MCF-7 | breast: | |
7 | chr21:16586940..16589372-chr21:16591214..16594501,3 | MCF-7 | breast: | |
8 | chr21:16586904..16589804-chr21:16590773..16592275,2 | K562 | blood: | |
9 | chr21:16249191..16252092-chr21:16587437..16590052,2 | MCF-7 | breast: | |
10 | chr21:16421751..16443998-chr21:16557859..16589610,273 | MCF-7 | breast: | |
11 | chr21:16581111..16587442-chr21:16661859..16666667,10 | MCF-7 | breast: | |
12 | chr21:16586904..16589804-chr21:16590773..16592275,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NRIP1-5 | chr21:16588147-16588197 | NONHSAT081196 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000180530 | chromatin interactions |
ENSG00000236471 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112945596 | chr21:16586498-16586499 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs544636367 | chr21:16586525-16586526 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs560688622 | chr21:16586526-16586527 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs2823151 | chr21:16586551-16586552 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs542751570 | chr21:16586584-16586585 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs188358896 | chr21:16586612-16586613 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs13053033 | chr21:16586623-16586624 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs554153331 | chr21:16586664-16586665 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs551126830 | chr21:16586669-16586670 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs12106385 | chr21:16586682-16586683 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs13046108 | chr21:16586731-16586732 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs527604842 | chr21:16586748-16586749 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs149911548 | chr21:16586769-16586770 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs2823152 | chr21:16586772-16586773 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs535510764 | chr21:16586797-16586798 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs549454182 | chr21:16586832-16586833 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs74902060 | chr21:16586839-16586840 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs538222853 | chr21:16586840-16586841 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs143948398 | chr21:16586855-16586856 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs193280329 | chr21:16586947-16586948 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs574147770 | chr21:16587010-16587011 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs374965196 | chr21:16587011-16587012 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs554364890 | chr21:16587046-16587047 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs185492400 | chr21:16587073-16587074 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs562479526 | chr21:16587117-16587118 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs2823153 | chr21:16587118-16587119 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs562590631 | chr21:16587200-16587201 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs545019395 | chr21:16587250-16587251 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs576088041 | chr21:16587265-16587266 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs544963023 | chr21:16587266-16587267 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs565066930 | chr21:16587288-16587289 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs187927102 | chr21:16587302-16587303 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs191313154 | chr21:16587314-16587315 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs142067312 | chr21:16587317-16587318 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs184188763 | chr21:16587335-16587336 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs188517308 | chr21:16587341-16587342 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs181250323 | chr21:16587383-16587384 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs529830772 | chr21:16587387-16587388 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs549743923 | chr21:16587388-16587389 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs112786282 | chr21:16587389-16587390 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs537974975 | chr21:16587403-16587404 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs531179768 | chr21:16587430-16587431 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs551717312 | chr21:16587472-16587473 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs9808777 | chr21:16587477-16587478 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs2823154 | chr21:16587487-16587488 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs370010085 | chr21:16587533-16587534 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs554499842 | chr21:16587544-16587545 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs567997917 | chr21:16587587-16587588 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs566597978 | chr21:16587590-16587591 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs533880921 | chr21:16587736-16587737 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
22q11.2 microdeletion syndrome | 19750312 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20409316 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:16583800-16586600 | Enhancers | HepG2 | liver |
2 | chr21:16585400-16587800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr21:16585400-16592000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
4 | chr21:16585600-16591400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr21:16586000-16591400 | Weak transcription | Primary hematopoietic stem cells | blood |
6 | chr21:16586400-16592400 | Weak transcription | Liver | Liver |
7 | chr21:16586600-16587800 | Weak transcription | HepG2 | liver |
8 | chr21:16587800-16588600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr21:16588600-16591400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr21:16590200-16592200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr21:16591200-16591400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr21:16591200-16592200 | Weak transcription | HepG2 | liver |
13 | chr21:16591400-16592200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr21:16591400-16592200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr21:16591400-16592400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr21:16591400-16592400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr21:16591400-16595200 | Enhancers | Primary hematopoietic stem cells | blood |
18 | chr21:16591600-16597400 | Enhancers | Primary monocytes fromperipheralblood | blood |